Microvascular endothelial cells (CMECs) oxidative damage resulting from
hypoxia/reoxygenation (H/R) injury is responsible for microcirculation perfusion …

Background—Although randomized trials suggest that transfer for primary percutaneous
coronary intervention (X-PCI) in ST-segment–elevation myocardial infarction is superior to …

There remains uncertainty over optimal antithrombotic management strategy for patients
with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing …

Aims Myocardial haemorrhage is a common complication following reperfusion of ST-
segment-elevation acute myocardial infarction (MI). Although its presence is clearly related …

El síndrome coronario agudo es una de las principales causas de mortalidad, morbilidad y
coste sanitario en España. Los objetivos del presente estudio son estimar el número de …

Background Intracoronary administration of an abciximab bolus during a primary
percutaneous coronary intervention results in a high local drug concentration, improved …

Objectives Left ventricular (LV) remodeling after acute myocardial infarction (AMI) is
associated with a poor prognosis and an impaired quality of life. We have shown earlier that …

Despite therapeutic improvements, cardiogenic shock (CS) remains the most common
cause of death in patients with acute myocardial infarction (AMI). In addition to percutaneous …

The evidence for the cardioprotective nature of omega-3 fatty acids is abundant, and
currently available data indicate that patients with known coronary heart disease should …

ESC clinical practice guidelines for the management of acute myocardial infarction in
patients with ST segment elevation: Working Group for the management of acute myocardial …